The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; PharmaMar; Roche
Research Funding - AstraZeneca; PharmaMar; Roche
The MITO8 phase III international multicenter randomized study testing the effect on survival of prolonging platinum-free interval (PFI) in patients with ovarian cancer (OC) recurring between 6 and 12 months after previous platinum-based chemotherapy: A collaboration of MITO, MANGO, AGO, BGOG, ENGOT, and GCIG.
 
Sandro Pignata
Honoraria - AstraZeneca; pharmamar; Roche
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche
Research Funding - Roche
 
Giovanni Scambia
No Relationships to Disclose
 
Francesco Raspagliesi
No Relationships to Disclose
 
Viviana Murgia
No Relationships to Disclose
 
Carmela Pisano
No Relationships to Disclose
 
Vanda Salutari
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; PharmaMar; Roche
Research Funding - AstraZeneca; PharmaMar; Roche
 
Alessandra Bologna
No Relationships to Disclose
 
Roberto Sorio
No Relationships to Disclose
 
Gabriella Ferrandina
Travel, Accommodations, Expenses - PharmaMar
 
Cosimo Sacco
No Relationships to Disclose
 
Ignace Vergote
No Relationships to Disclose
 
Gennaro Cormio
No Relationships to Disclose
 
Enrico Breda
No Relationships to Disclose
 
Saverio Cinieri
No Relationships to Disclose
 
Sabrina Chiara Cecere
No Relationships to Disclose
 
Uwe A. G. Wagner
No Relationships to Disclose
 
Gennaro Daniele
Honoraria - Bayer Schering Pharma
 
Ciro Gallo
No Relationships to Disclose
 
Francesco Perrone
Honoraria - Amgen; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Lilly; Novartis; Roche; Roche
Research Funding - Amgen/Dompé (Inst); GlaxoSmithKline (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bayer Schering Pharma; Lilly; Roche; Roche
 
Maria Carmela Piccirillo
No Relationships to Disclose